Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis

Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines

(2020) Xin Liu et al.   Journal of Genetics and Genomics

Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV

(2020) Ping-Ing Lee et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV

(2020) Jiabao Xu et al.   Viruses-Basel

Going global – Travel and the 2019 novel coronavirus

(2020) Alfonso J. Rodríguez-Morales et al.   Travel Medicine and Infectious Disease

Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?

(2020) Irene Karampela et al.   ARCHIVES OF MEDICAL RESEARCH

Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors

(2019) Kyeong-Ok Chang et al.   Viruses-Basel

Fluoroquinolones structural and medicinal developments (2013–2018): Where are we now?

(2019) Ghadeer A.R.Y. Suaifan et al.   BIOORGANIC & MEDICINAL CHEMISTRY

KDEEP: Protein–Ligand Absolute Binding Affinity Prediction via 3D-Convolutional Neural Networks

(2018) José Jiménez et al.   Journal of Chemical Information and Modeling

Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules

(2018) Joanna Fedorowicz et al.   MONATSHEFTE FUR CHEMIE

Mechanisms of quinolone action and resistance: where do we stand?

(2017) Susana Correia et al.   JOURNAL OF MEDICAL MICROBIOLOGY

QwikMD — Integrative Molecular Dynamics Toolkit for Novices and Experts

(2016) João V. Ribeiro et al.   Scientific Reports

Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?

(2014) A. Dalhoff   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Fluoroquinolones inhibit HCV by targeting its helicase

(2011) Irfan A Khan et al.   ANTIVIRAL THERAPY

Efficacy and Safety of Ciprofloxacin for Prophylaxis of Polyomavirus BK Virus–Associated Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

(2010) Ashley N. Miller et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Safety Profile of the Respiratory Fluoroquinolone Moxifloxacin

(2009) Françoise Van Bambeke et al.   DRUG SAFETY